Bpifrance

Tech solution to accelerate biodiversity restoration.

Mabqi, headquartered in Grabels, France, is a biopharmaceutical company specializing in immunotherapy. It operates an antibody discovery platform, enabling the identification and development of innovative, proprietary therapeutic molecules.

HEXANA develops an energy platform that integrates sodium-cooled fast-neutron reactors with a thermal management system and high-temperature storage to deliver flexible on-demand electricity and process heat while reducing nuclear waste. The modular reactors are designed for both on-site and grid-scale deployment, enabling flexible power production and direct industrial heat applications with emphasis on safety and waste management.

NEBULA maps 3D macromolecule using dataset-free genAI and physics, enhancing drug target discovery, which forms the basis of all new drugs.

Mirabelle is a technology-driven financial services company focused on addressing the financial needs of retirees. It specializes in offering reverse mortgage loans and life annuities, with a commitment to providing secure and informed decision-making processes. The company's core business involves advising on life annuity financing, ensuring retirees have access to guaranteed monthly income supplements, and assisting with senior housing renovations. Mirabelle's mission is to enable retirees and their families to live comfortably and securely in their homes during their golden years.

Founded in 2011, Lingua Custodia specializes in developing SaaS-based software for machine translation tailored to the financial domain. Its flagship product, VERTO, offers customized translation solutions for finance professionals, serving financial institutions, language service providers, and other finance-related entities.

Iadys designs, develops, and delivers robotic and AI innovations aimed at environmental preservation. The company's flagship product, the Jellyfishbot, is a robot that collects floating waste and oil in water bodies and performs underwater measurements. Iadys also offers the Mobile Oil Skimmer, which is used for oil spill response. These products are designed to access and clean hard-to-reach areas, contributing to cleaner and safer aquatic environments.

Fudzs specializes in sustainable bioeconomy, developing eco-friendly cell bioproduction processes using cutting-edge bioreactor technology. By integrating advanced biomaterial engineering with cellular science, Fudzs enables mass production of cells at reduced costs, opening new market opportunities.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

Aura Aero designs and manufactures aircraft with a focus on accelerating air transport decarbonization.

GenoMines is a company focused on sustainable mining through innovative biological methods. It specializes in using plant-based technologies to extract critical metals from soils that are below traditional cut-off grades. By genetically enhancing hyperaccumulator plants, GenoMines leverages nature's ability to absorb metals, thereby not only sustainably mining these resources but also depolluting soils and increasing the availability of agricultural sites. This approach addresses significant environmental and societal challenges associated with conventional mining methods, aiming to support the transition to green energy in a responsible manner.

Biodol Therapeutics develops first-in-class therapies for chronic pain by targeting the FLT3 receptor, a receptor tyrosine kinase expressed on sensory neurons that triggers and sustains neuropathic pain. The company advances extracellular inhibitors of FLT3 to block ligand binding and disrupt pain signaling, with goals to reduce allodynia, hypersensitivity and spontaneous pain while preserving normal nervous system function. By pairing FLT3 inhibition with opioid analgesia, Biodol Therapeutics aims to enhance pain relief and potentially lower opioid-related safety risks. Founded in 2015 and based in Clapiers, France, the company collaborates with academic researchers to validate FLT3 as a therapeutic target for chronic pain.

Hephaistos Pharma is a biotechnology company developing an immunotherapy platform aimed at producing advanced oncology treatments. Its platform enhances commercialized antibodies by stimulating the immune system, turning 'cold' tumors into targets for immune response.

Magnetfab manufactures micromagnets for microelectronic applications using thin-film sputtering to produce rare-earth magnets with micron-level precision and wafer-scale fabrication. This enables integration of compact magnetic components into advanced electronic systems across consumer electronics, robotics, and quantum computing, prioritizing reliability and scalability.

Touch Sensity is an information technology company focused on the development of sensitivity technology that enhances the interaction between objects and their environments. It specializes in Internet of Things (IoT) applications and advanced sensor technology, creating solutions that are adaptable to various sizes, shapes, and surface topologies. The company's innovative approach is sensorless and non-invasive, allowing for the comprehensive capture of data related to pressure, extension, and deformation across complete surfaces. This capability enables clients to gather and analyze detailed information about physical interactions, thereby enhancing the functionality and responsiveness of their products and systems.

Tribun Health specializes in digital health solutions for cancer detection. It develops innovative systems that enable diagnostic laboratories and pharmaceutical/biotech companies to manage, analyze, and share cellular images efficiently.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

Surge is a biotechnology company dedicated to enhancing surgical outcomes for patients. It has developed an advanced immunological model known as Surge2surgery, which predicts postoperative infections. This innovative platform integrates a single-cell analysis of the immune system conducted prior to surgery with clinical data, utilizing a proprietary machine-learning algorithm. By examining millions of immune cells from a small blood sample, Surge's technology simulates surgical trauma in a controlled environment, allowing for improved predictions and potentially better patient care.

Alice & Bob is a Paris-based quantum computing hardware company founded in 2020. It develops universal quantum computers designed to enable industries and researchers to tackle complex problems. The company focuses on integrating error correction into its hardware, using cat qubits with built-in error resilience, and provides a platform with cloud access for remote testing and expert support. This combination aims to deliver early quantum computational advantages for practical applications in science and industry.

Sequans Communications designs and supplies cellular semiconductor solutions for broadband Internet of Things markets, offering 5G and 4G chips and modules for massive, broadband, and critical IoT applications. Its product platforms include Monarch LTE-M/NB-IoT and Calliope Cat 1 for low-power, integrated IoT deployments, Cassiopeia Cat 4/Cat 6 for 4G and 5G, and Taurus for residential, enterprise, and industrial use. Founded in 2003 and headquartered in Paris, the company operates globally with offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China. Its customer base spans smart mobility and logistics, smart utility meters, smart cities and industries, e-health, and smart homes, reflecting a focus on cellular semiconductor solutions for a range of IoT connectivity needs.

ABIONYX Pharma SA is a French biopharmaceutical company established in 2005, currently based in Labege. It specializes in the discovery and development of therapies targeting high-density lipoprotein (HDL) for treating cardiovascular and metabolic diseases. The company's primary focus is on developing HDL mimetics to rapidly regress atherosclerotic plaque in high-risk patients. Its lead product candidate, CER-001, is a Phase II clinical trial asset designed to mimic the properties of pre-beta HDL for treating post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients. Additionally, ABIONYX Pharma has another drug candidate, CER-209, in Phase I trials for metabolic diseases and liver-related conditions such as atherosclerosis and non-alcoholic steato-hepatitis.

Sunver is a start-up offering the first fully plug & play B2B SaaS solution for tourism establishments and restaurants, enabling them to create and configure a Guest App in just a few minutes.

UniFox is an AI-powered ecosystem focused on sustainable investment, integrating green energy and eco-responsible technologies into its offerings for both individual and institutional investors. The company operates through four divisions: B2C, B2B, Capital Ventures, and Green DeFi. Its flagship product, VulpesAI, is a multi-modal AI engine that analyzes market data, sentiment, and environmental, social, and governance (ESG) factors to create optimized investment strategies. VulpesAI is designed to be environmentally friendly, utilizing renewable energy sources and low-frequency micro-servers to minimize its carbon footprint. The B2C segment provides AI-driven portfolio management, enabling users to access comprehensive market insights and tailor investment strategies based on AI-generated signals. In the B2B sector, UniFox delivers institutional solutions through REST API access to advanced data and metrics for large-scale investments and green projects. Its Green DeFi division finances sustainable technology initiatives, utilizing decentralized finance methods, eco-taxed products, and tokens to support environmentally friendly ventures. UniFox's mission is to democratize investment, making it more accessible and aligned with ecological values while addressing common trading challenges faced by novice investors.

I.Ceram SA is a France-based company that specializes in the design, manufacture, and marketing of alumina bio-ceramic implants for various joints of the human body. Founded in 2005 and headquartered in Limoges, I.Ceram offers a range of implants for the ankle, knee, hip, spine, shoulder, wrist, skull, tibia, and foot, as well as osteosynthesis products. The company operates both domestically and internationally, emphasizing innovation and high-quality materials in its product offerings. I.Ceram is a subsidiary of Investissement Développement.

Novacium operates as an innovative start-up that specializes in the next generation material development.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

HUVY employs artificial intelligence to optimize dermatological treatment pathways and deliver critical medical information in real-time.

EyeGauge is a Paris-based Deep Tech company focused on the maritime industry. It aims to accelerate decarbonization by automating data collection from ships' systems, enabling consistent, comprehensive emission tracking and analysis. This helps shipowners optimize operations and comply with regulations like EEXI and CII.

Astraveus is developing the Lakhesys platform, an end-to-end cell foundry for cell and gene therapy manufacturing. The platform uses deep process optimization and single-use microfluidic bioprocessors to produce autologous therapies with reduced inputs and infrastructure needs, lowering costs and logistical barriers. By enabling automated, patient-specific biomanufacturing, Astraveus aims to improve access to transformative CGTs. The system builds equipment tailored for each patient to use autologous cells, leveraging microfluidic chip technology to convert cells into therapeutic agents. The approach seeks to scale production of cell and gene therapies while minimizing environmental impact and resource use, supporting more sustainable manufacturing at lower cost.

Injectpower specializes in developing energy storage technologies and micro-batteries tailored for medical implants. Their core product is a small, solid-state battery that powers implantable devices, enabling them to function as sensors or actuators for extended periods without the need for recharging. With over 16 years of research and 40 patents, Injectpower's batteries are manufactured using a proven semiconductor supply chain, ensuring high reliability. The company's innovative solutions include batteries for devices that monitor intraocular pressure in glaucoma patients and intracranial pressure and fluid flow, allowing physicians to remotely monitor and diagnose conditions more effectively.

F&B advertising webapp

Spark Cleantech is a pioneering company developing a plasma technology to convert greenhouse gases into hydrogen fuel. Their proprietary process, called plasmolysis, uses cold pulsed plasma discharges to convert methane or carbon dioxide and methane mixtures into valuable products such as hydrogen, solid carbon, and carbon monoxide. This technology enables the production of competitive, on-site hydrogen, serving as a direct substitute for fossil fuels in decarbonizing industrial heat and powering the transport industry with carbon-neutral hydrogen fuel.

Global Bioenergies SA specializes in developing a biological process that converts renewable resources into isobutene, a crucial petrochemical building block used in fuels, plastics, organic glass, and elastomers. The company, based in Evry, France, is notable for being one of the few globally and the only one in Europe focusing on this innovative fermentation technology. It operates an industrial pilot plant and is nearing the completion of a demonstration plant in Germany, alongside preparing for its first full-scale production facility in collaboration with Cristal Union, known as IBN-One. In addition to isobutene, Global Bioenergies has expanded its capabilities to include the production of propylene and butadiene, both vital components in the petrochemical sector. The company was founded in 2008 and continues to enhance the efficiency of its processes while offering engineering services related to gas fermentation.

Circul'Egg transforms recycled eggshells into calcium carbonate powder and shell membrane powder for use in animal feed, nutraceuticals, and cosmetics. It promotes sustainable practices by repurposing industrial co-products.

Remixt is a leading Diversity, Equity and Inclusion tech platform dedicated to preventing key HR risks caused by harassment and discrimination. The company is headquartered in Paris, France, with employees in Paris, San Francisco, Toulouse and Annecy. Remixt’s clients include global corporations Heineken, Société Générale, Accenture, Groupe BPCE-Natixis and Hexagon. For more information: http://www.remixt.co

Eramet is a global leader in alloy metals such as manganese and nickel, focusing on high-end metallurgy. The company also explores growth opportunities in mineral sands like titanium dioxide and zircon, lithium, and recycling sectors.

Toopi Organics is a biotechnology company based in Langon, France, established in 2019. It develops microbiological and agricultural technologies to transform human urine into fertilizers and biostimulants for agriculture. The company collects and upcycles human urine, depollutes and enriches it with microorganisms to provide natural, economical, and efficient alternatives to chemical fertilizers. Its products include Arbop and Vitip, which support plant growth and crop health, offering farming communities an environmentally conscious option for nutrient supply.

Phagos develops personalized bacteriophage solutions as a sustainable alternative to antibiotics.

Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

Deemea develops an AI-driven platform for clinical research, streamlining imaging data management. Its integrated copilot ensures efficiency and reliability in data processing.

GenoMines is a company focused on sustainable mining through innovative biological methods. It specializes in using plant-based technologies to extract critical metals from soils that are below traditional cut-off grades. By genetically enhancing hyperaccumulator plants, GenoMines leverages nature's ability to absorb metals, thereby not only sustainably mining these resources but also depolluting soils and increasing the availability of agricultural sites. This approach addresses significant environmental and societal challenges associated with conventional mining methods, aiming to support the transition to green energy in a responsible manner.

AlgoTherapeutix develops topical treatments for complex pain conditions, focusing on chemotherapy-induced peripheral neuropathy and diabetic neuropathic pain. The company repurposes existing drugs to target damaged nerve fibers in the skin, avoiding systemic side effects of oral drugs.

Oneleaf is a startup dedicated to making hypnosis more accessible through its innovative app, which assists users in engaging with self-hypnosis techniques. The platform offers a variety of guided programs aimed at addressing wellness issues such as depression, anxiety, smoking cessation, and weight loss. By leveraging expert guidance in a digital format, Oneleaf enables individuals to tackle harmful habits and enhance their overall well-being. The company aims to empower a billion people to realize their potential through self-hypnosis, promoting personal growth and healthier lifestyles.

NFL Biosciences is a biotechnology company focused on developing solutions for tobacco addiction. The company specializes in research and development of medicines that utilize both botanical and pharmaceutical agents to aid individuals attempting to quit smoking. Its primary product, NFL-101, is a clinically developed botanical drug designed specifically to target smoking addiction. This innovative treatment contains minimal amounts of nicotine and is formulated from well-characterized natural tobacco leaf proteins, offering a unique approach to support smokers in overcoming their addiction.

Shortcut supports CGPs and enables automation of emailing, invitations and customer communications.

Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

Centralize and automate all possible customer-centric activities with external accounts. Involve your customers or suppliers directly in the platform. Part of AWS accelerator program and received the status of a Jeune Entreprise Universitaire.

Phagos develops personalized bacteriophage solutions as a sustainable alternative to antibiotics.

Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

Ex9 provides automated transportation services for logistics operators. It deploys a fleet of eco-friendly robot-tractors to automate trailer movements within closed areas like warehouses and distribution hubs, enabling round-the-clock operations, cost reduction, and significant CO2 emission cuts.

Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer. The firm focuses on creating a pipeline of small molecules that specifically target the eukaryotic translation initiation factor-4A to address resistance in patients who have become unresponsive to existing targeted therapies. With a primary emphasis on melanoma, Ribonexus aims to enhance the effectiveness of current treatments by restoring sensitivity to them in patients whose cancers have developed resistance. Through its research and development efforts, Ribonexus seeks to contribute meaningful advancements in oncology and improve treatment outcomes for patients facing challenging cancer types.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Susu delivers comprehensive health services to families in the African diaspora, spanning preventive care, medical treatments, chronic disease management, and access to authentic medications. Through a bundled, long-term care offering, Susu enables planned health support, regular monitoring of conditions such as pregnancy and chronic diseases, and connects users to quality healthcare services and insurance options, with a focus on affordability and accessibility.

1 in 3 travellers extend their stay thanks to remote work. Improve the profitability of your space by becoming a remote work hub. Since 2020, more than 100 spaces have trusted Desk.

VistaCare is a French company specializing in innovative medical devices for treating acute and chronic wounds. It develops, manufactures, and distributes products designed to enhance patient quality of life and simplify caregiver routines by reducing treatment times and hospital stays.

Diaccurate is a biotechnology company based in Paris, France, founded in 2012. The company focuses on researching and developing innovative treatments for various medical conditions, including HIV infection, endocrine-resistant metastatic breast tumors, glioblastoma, and refractory acute myeloid leukemia. Diaccurate is dedicated to exploring new frontiers in oncology to create novel therapeutic approaches aimed at combating difficult-to-treat cancers and improving patient outcomes.

Pherecydes Pharma specializes in the research and development of lytic bacteriophages for therapeutic applications, focusing on antibiotic resistance. Established in 2006, the company is based in Romainville, France.

Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Echoliv is a medical technology company specializing in artificial intelligence solutions for abdominal ultrasound. They develop software, namely Ultraliv, designed to aid radiologists and hepatologists in early-stage detection of hepatocellular carcinoma (HCC), the most common type of liver cancer. The algorithm enhances diagnostic capabilities by identifying nodules that may have been overlooked by practitioners during ultrasound screening.

Luos develops open-source software that streamlines hardware development by making it as flexible as software. Their platform connects all components of electronic devices into a single system image, simplifying driver creation and application deployment for developers.

Deemea develops an AI-driven platform for clinical research, streamlining imaging data management. Its integrated copilot ensures efficiency and reliability in data processing.

Adeunis designs, manufactures, and markets connected objects and Internet of Things (IoT) solutions for various sectors, including smart buildings, industrial optimization, and connected agriculture. The company offers a range of products, such as radio frequency transmission modules, wireless transmission systems, and telemetry systems, tailored to meet the specific needs of its customers. Adeunis also provides services like on-site radio mapping, deployment, training, and data processing to support the management of buildings and infrastructure. Based in Crolles, France, the company focuses on creating customized radio solutions and ready-to-use systems that enhance connectivity and efficiency across multiple applications.

Founded in 2017, Alkion BioInnovations specializes in developing natural plant active ingredients for pharmaceutical applications using proprietary semi-industrial technologies. The company focuses on environmentally friendly and consumer-beneficial products.

C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

Biophytis SA is a clinical-stage biotechnology company headquartered in Paris, France, dedicated to developing therapeutics aimed at slowing the degenerative processes associated with aging and enhancing functional outcomes for patients with age-related diseases. The company is focused on activating key biological resilience pathways that may protect against the effects of various biological and environmental stresses linked to these diseases. Biophytis's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule designed for treating neuromuscular conditions such as sarcopenia and Duchenne muscular dystrophy. Additionally, its second candidate, Macuneos (BIO201), targets retinal diseases, including age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon to further the development of Sarconeos. Since its founding in 2006, Biophytis has aimed to position itself as a leader in the emerging field of aging science by providing innovative therapies for patients with limited treatment options.

OncoDiag is a biotechnology company based in Normandy, France, specializing in the development of non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, Urotest, is a urine test designed for the diagnosis and monitoring of bladder cancer. Additionally, the company is advancing its pipeline with Colodiag, which focuses on the early detection of colorectal cancer. OncoDiag's portfolio also includes a tissue-based test for predicting non-evolutive localized prostate cancer. By offering these innovative diagnostic solutions, OncoDiag aims to enhance the capabilities of healthcare professionals in cancer diagnosis and management.

Luos develops open-source software that streamlines hardware development by making it as flexible as software. Their platform connects all components of electronic devices into a single system image, simplifying driver creation and application deployment for developers.

Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Bybr is a company that focuses on enhancing local commerce by connecting consumers with their preferred brands and experiences through an online platform. It enables direct access to official commercial channels, facilitating personal interactions between customers and businesses. Bybr employs advanced technologies, including a universal scanner that recognizes various signs such as logos, barcodes, and QR codes, to streamline the customer experience. Its 1Scan to connect solution allows for seamless engagement with brands, thereby transforming how local commerce aligns with customer expectations. Bybr's platform serves as a marketplace that not only connects brands and consumers but also fosters collaborations between influential creators and brands, enabling effective marketing through multiple media channels. This approach allows businesses to enhance their visibility and engage with customers in a more meaningful way.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Multiwave Technologies develops breakthrough magnetic resonance imaging and positron emission tomography devices, including metamaterial MRI antennas designed by its French unit. The company aims to improve MRI image quality and support clinical decision making, including portable MRI capabilities and sensor-based performance analysis. Founded in 2015 in Switzerland, it is headquartered in Geneva and conducts research and development in France, reflecting an international footprint. The business is recognized for its metamaterial MRI antenna design and positions itself as a deep science imaging innovator in neurology and other medical imaging applications.

Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

Xenothera is a biotechnology company that specializes in xenotherapy, focusing on the development of innovative immunological treatments. Utilizing a unique technological platform, Xenothera combines expertise in animal genetics with advanced immunology processes to create new therapeutic approaches for various medical conditions, including immunomodulation and infectious diseases. The company is particularly noted for its development of hyperimmune polyclonal sera, which represents a new generation of passive immunotherapy. By controlling the entire process—from the selection of immunogens to the purification of immunoglobulins—Xenothera is able to accelerate the development and market authorization of its therapies, thereby facilitating timely access to novel treatments for patients.

Quantum Surgical develops surgical robotics and intelligent tools to democratize minimally invasive liver cancer treatment. The company's robotics support percutaneous ablation therapies and related minimally invasive procedures, aiming to improve patient outcomes and safety in interventional oncology. By enabling precise robotic assistance, Quantum Surgical seeks to help healthcare providers perform safer, more effective liver cancer interventions, with potential for higher cure rates and shorter recovery times.

Multiwave Technologies develops breakthrough magnetic resonance imaging and positron emission tomography devices, including metamaterial MRI antennas designed by its French unit. The company aims to improve MRI image quality and support clinical decision making, including portable MRI capabilities and sensor-based performance analysis. Founded in 2015 in Switzerland, it is headquartered in Geneva and conducts research and development in France, reflecting an international footprint. The business is recognized for its metamaterial MRI antenna design and positions itself as a deep science imaging innovator in neurology and other medical imaging applications.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

KAPTREK is the first French & European proprietary HW / SW platform declined on several markets : Outdoor sports, Industry 4.0, E-Mobility, Health & Care, Army, Sportech. KAPTREK is an all in one electronic product, allowing customized devs.

TreeFrog Therapeutics is a stem cell company focused on scalable production of stem cells for cell therapies. It develops and uses a proprietary end-to-end 3D bioreactor-based platform called C-Stem to enable scalable, cGMP-compliant manufacturing. Founded in 2018 and based in Pessac, France, the company aims to secure cell production and quality, accelerate clinical development, and improve market access by reducing treatment costs. The platform addresses manufacturing bottlenecks in the cell therapy sector, offering an integrated solution from cell culture to manufacturing readiness to support safe, affordable stem cell therapies.

Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

Founded in 2015, ImCheck Therapeutics specializes in developing immunotherapeutics targeting members of the butyrophilin super-family for treating a range of autoimmune diseases, with a primary focus on immuno-oncology.

Peculium is a company based in Nanterre, France, that focuses on providing advanced wealth management services tailored for digital assets. Established in 2017, Peculium has developed a cryptocurrency savings management system designed to help clients manage their investments in the ever-evolving landscape of digital currencies. Through its innovative platform, the company aims to enhance the financial well-being of its users by offering sophisticated investment solutions that cater to the unique needs of the cryptocurrency market.

Skipper NDT specializes in contactless magnetic inspection technology for pipeline operators. Their UAV-based pipeline mapping service offers centimetric precision, enabling access to remote locations and optimizing maintenance costs while enhancing safety standards.

TreeFrog Therapeutics is a stem cell company focused on scalable production of stem cells for cell therapies. It develops and uses a proprietary end-to-end 3D bioreactor-based platform called C-Stem to enable scalable, cGMP-compliant manufacturing. Founded in 2018 and based in Pessac, France, the company aims to secure cell production and quality, accelerate clinical development, and improve market access by reducing treatment costs. The platform addresses manufacturing bottlenecks in the cell therapy sector, offering an integrated solution from cell culture to manufacturing readiness to support safe, affordable stem cell therapies.

Founded in 2017, Alkion BioInnovations specializes in developing natural plant active ingredients for pharmaceutical applications using proprietary semi-industrial technologies. The company focuses on environmentally friendly and consumer-beneficial products.

Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.

Capte is a technology company that specializes in developing and integrating Internet of Things (IoT) solutions for various industries, with a focus on transportation and marine sectors. The company's core business involves creating predictive monitoring and fleet management technologies that enable real-time telemetry, vehicle diagnostics, and predictive maintenance. By leveraging these solutions, Capte helps transit agencies and fleet operators reduce vehicle downtime, optimize performance, and lower operational costs, ultimately facilitating the transition towards more efficient and sustainable transportation systems.

DNA Script is a Paris-based company that develops synthetic biology tools focused on DNA synthesis. It employs enzymatic processes to produce synthetic nucleic acids, including oligonucleotides, enabling genomics and molecular biology applications. Founded in 2014, it introduced the SYNTAX benchtop DNA printer to provide labs with greater workflow control and faster access to results. By producing DNA through natural enzymes, the company aims to accelerate research and the development of new therapeutics.

DNA Script is a Paris-based company that develops synthetic biology tools focused on DNA synthesis. It employs enzymatic processes to produce synthetic nucleic acids, including oligonucleotides, enabling genomics and molecular biology applications. Founded in 2014, it introduced the SYNTAX benchtop DNA printer to provide labs with greater workflow control and faster access to results. By producing DNA through natural enzymes, the company aims to accelerate research and the development of new therapeutics.

Surfact'Green is a company that develops, produces, and markets patented ecological surfactants derived from agro-resources, including algae and sugar beet co-products. Established in 2011 as a business unit at the Rennes National School of Chemistry, Surfact'Green builds on over a decade of research conducted by the Organic and Supramolecular Chemistry team. The company focuses on green chemistry, creating eco-compatible and biodegradable surfactants that serve as sustainable alternatives to petrochemical derivatives. These surfactants are solvent-free, sulfate-free, and readily biodegradable, enabling businesses to reduce their environmental and human health impacts while maintaining product efficacy. Collaborations with public and private laboratories, as well as industrial organizations, further enhance Surfact'Green's innovative approach to sustainable surfactant solutions.

Eversend is a company that develops a multi-currency e-wallet that lets users exchange, spend, and send money across currencies. The platform supports currency exchange, crypto purchases, virtual cards, and payments to bank accounts and mobile wallets, using a digital gateway and blockchain technology to reduce fees and foreign exchange costs. Based in Paris, France, Eversend plans to expand its offering to include personal loans, savings and group savings, merchant payments, and investments in the future.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Internest develops a precise positioning system for rotating winged vehicles. The system is an embedded solution featuring firmware and hardware that provides robust and accurate positioning information across varying visibility, weather, and environmental conditions via a local landing system. This enables security, military, and maritime operators to support drones and helicopters in critical operations with improved flight safety.

Internest develops a precise positioning system for rotating winged vehicles. The system is an embedded solution featuring firmware and hardware that provides robust and accurate positioning information across varying visibility, weather, and environmental conditions via a local landing system. This enables security, military, and maritime operators to support drones and helicopters in critical operations with improved flight safety.

VeriCampus is a technology company that focuses on enhancing student support services for colleges and universities through the use of artificial intelligence. The company develops AI-driven chatbots, known as 'Campus Assistants,' which are designed to embody the character and knowledge of the institution, thereby helping students effectively navigate their academic journeys. VeriCampus aims to make education more accessible and affordable by providing educational institutions with a comprehensive messaging platform that facilitates access to essential products, services, and information. This platform not only fosters increased engagement across various facets of the educational experience but also allows schools to deliver personalized support at a reduced cost.

Mash&Co is an innovative digital content creator focused on edutainment. It produces engaging, interactive experiences for children, combining storytelling, animation, and games to teach cultural themes and STEAM subjects. The company operates globally, partnering with businesses for co-production and distribution.

Conscious Labs specializes in developing brain-computer interface (BCI) technology for research purposes. They focus on creating EEG sensors that can be integrated into consumer electronics such as headphones, VR/AR devices, and wearables.

Seamless Waves designs and implements reconfigurable RF transceivers that sweep the spectrum to identify the least occupied band and establish communication using the most suitable wireless standard. The devices leverage efficient RF analog-to-digital converters to achieve low power consumption suitable for portable applications. The company also provides silicon-proven Analog/RF IPs and virtual component models to support early system integration. Its technology supports dynamic spectrum sensing, frequency hopping, and spectrum scanning, enabling IoT, mobile, and defense uses to deliver efficient, secure, and energy-conscious connectivity.

Founded in 2017, Alkion BioInnovations specializes in developing natural plant active ingredients for pharmaceutical applications using proprietary semi-industrial technologies. The company focuses on environmentally friendly and consumer-beneficial products.